Purchase Short-Term Access
Pioglitazone was associated with lower risk for adverse cardiovascular events than rosiglitazone in older patients
Ananda Basu, MD
Annals of Internal Medicine 2010;152:JC2-13.
doi:10.7326/0003-4819-152-4-201002160-02013
Purchase Online access to this article for 24 hours
